JNJ just entered the fray as the newest bona fide COVID-19 "play" given its claim to have a serious vaccine candidate.The stock broke above range and MA resistance to kick off the week, and still has a bullish trend on a long time frame according to the Ichimoku Cloud indicator.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.